<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">475847172</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180406123917.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170329e20000201xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1023/A:1008986225602</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1023/A:1008986225602</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Integrating the patient's views into the measurement of quality of life: Examples from the peri- and post-menopausal periods</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Anne Marciniak, Mauro Niero]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">This paper focuses on patient's views and how they are addressed in current approaches to the measurement of health related quality of life (QOL) during the peri-and post-menopausal periods. Although all QOL questionnaires are meant to be subjective as they ask for self-reported assessments, they do differ in their rationale, particularly the standards against which patient QOL is assessed. These standards can be defined either by the researchers, the doctors, the community or the patients themselves. Approaches to measurement include the assessment of symptoms, physical function, the ability to perform daily activities, the achievement of personal expectations and motivational needs, well-being and utility theory. The contribution that each approach can make to the measurement of quality of life is examined and instruments such as those used during the peri- and post-menopausal periods are given as examples. The different underlying rationales have resulted in instruments that serve different purposes. The rationale therefore should be used as a guide for choosing the most appropriate measure according to whether the information is required to inform decision making by payers, clinicians or individuals. Further research is required to assess interventions for peri- and post-menopausal women in the context of their needs and expectations.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Kluwer Academic Publishers, 2000</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Concepts</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Peri-menopause</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Post-menopause</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Quality of Life</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Subjective views</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Marciniak</subfield>
   <subfield code="D">Anne</subfield>
   <subfield code="u">Pfizer Central Research, Sandwich, Kent, UK</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Niero</subfield>
   <subfield code="D">Mauro</subfield>
   <subfield code="u">University of Verona, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Quality of Life Research</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">9(2000-02-01), 775-784</subfield>
   <subfield code="x">0962-9343</subfield>
   <subfield code="q">9&lt;775</subfield>
   <subfield code="1">2000</subfield>
   <subfield code="2">9</subfield>
   <subfield code="o">11136</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1023/A:1008986225602</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1023/A:1008986225602</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Marciniak</subfield>
   <subfield code="D">Anne</subfield>
   <subfield code="u">Pfizer Central Research, Sandwich, Kent, UK</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Niero</subfield>
   <subfield code="D">Mauro</subfield>
   <subfield code="u">University of Verona, Italy</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Quality of Life Research</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">9(2000-02-01), 775-784</subfield>
   <subfield code="x">0962-9343</subfield>
   <subfield code="q">9&lt;775</subfield>
   <subfield code="1">2000</subfield>
   <subfield code="2">9</subfield>
   <subfield code="o">11136</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
